Clinical therapeutic strategy of recombinant human brain natriuretic peptide and dopamine in cardiorenal syndrome type 4 patients combined with hypotension
Aim of the present study is to investigate the clinical efficacy of recombinant human brain natriuretic peptide
Keywords
Cardiorenal syndrome type 4 (CRS4)
hypotension
rhBNP
dopamine
outcome
adverse reaction.
Metrics
DOI is not available
Clinical therapeutic strategy of recombinant human brain natriuretic peptide and dopamine in cardiorenal syndrome type 4 patients combined with hypotension | PJPS